2-ethyl-3t-(4-hydroxy-phenyl)-acrylic acid | 28166-40-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 2-ethyl-3t-(4-hydroxy-phenyl)-acrylic acid
• 英文别名: 2-Aethyl-3t-(4-hydroxy-phenyl)-acrylsaeure；(2E)-2-[(4-hydroxyphenyl)methylidene]butanoic acid
• CAS: 28166-40-7
• 化学式: C₁₁H₁₂O₃
• 分子量: 192.214
• InChiKey: BHRNSCAHRYQXGR-VQHVLOKHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  丁酸酐 、 对羟基苯甲醛 在 potassium n-butyrate 作用下， 生成 2-ethyl-3t-(4-hydroxy-phenyl)-acrylic acid
  参考文献：
  名称：

  Organic acids

  摘要：

  公开号：

  US02400433A1

文献信息

• BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS
  申请人：NOVARTIS AG

  公开号：US20170112805A1

  公开（公告）日：2017-04-27

  The present invention relates to compounds of formula I: in which n, m, X, Y 1 , R 1 , R 2 , R 3 , R 4 and R 5 are defined in the Summary of the Invention; capable of being both potent antagonists and degraders of estrogen receptors. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with aberrant estrogen receptor activity.

  本发明涉及公式I的化合物：其中n，m，X，Y1，R1，R2，R3，R4和R5在发明摘要中定义；能够同时作为雌激素受体的强拮抗剂和降解剂。本发明还提供了制备本发明化合物的方法，包含这些化合物的药物制剂，以及使用这些化合物和组合物在管理与异常雌激素受体活性相关的疾病或紊乱的方法。
• [EN] NEW 3-ARYL PROPIONIC ACID DERIVATIVES AND ANALOGS<br/>[FR] NOUVEAUX DERIVES D'ACIDE 3-ARYL PROPIONIQUE ET ANALOGUES
  申请人：ASTRAZENECA AB

  公开号：WO1999062871A1

  公开（公告）日：1999-12-09

  (EN) Novel 3-aryl proprionic acid derivatives and analogs, having general formula (I) and stereo- and optical isomers and racemates thereof as well as pharmaceutically acceptable salts, solvates and crystalline forms thereof, process for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.(FR) L'invention concerne de nouveaux dérivés d'acide 3-aryl-propionique et leurs analogues, ayant la formule générale (I). L'invention concerne également leurs stéréo-isomères, leurs isomères optiques, leurs racémates ainsi que leurs sels pharmaceutiquement acceptables, leurs solvates et leurs formes cristallines. L'invention concerne enfin leur procédé de production, les préparations pharmaceutiques les contenant et l'utilisation de ces composés dans des états cliniques associés une insulinorésistance.

  (中) 新型3-芳基丙酸衍生物及其类似物，具有通式（I）和其立体和光学异构体以及它们的盐，溶剂化合物和晶体形式，其制造方法，包含它们的制药制剂以及在与胰岛素抵抗有关的临床情况下使用这些化合物的用途。
• New 3-aryl propionic acid derivatives and analogs
  申请人：——

  公开号：US20040229949A1

  公开（公告）日：2004-11-18

  Novel 3-aryl propionic acid derivatives and analogs, process and intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.

  小说3-芳基丙酸衍生物和类似物，其制造过程和中间体，含有它们的制药制剂以及在与胰岛素抵抗相关的临床病症中使用这些化合物的用途。
• Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them
  申请人：AMANO PHARMACEUTICAL CO., LTD.

  公开号：EP0166542A2

  公开（公告）日：1986-01-02

  A triterpenyl ester of organic acid other than triterpenyl esters of ferulic acid and of monobasic and dibasic saturated fatty acids. A process for producing a triterpenyl ester of organic acid other than esters of ferulic acid and of monobasic and dibasic saturated fatty acids, which comprises the reaction of a triterpenyl alcohol with an acid halide of the corresponding organic acid. A pharmaceutical composition for treatment of hyperlipidemia comprising a pharmaceutical carrier and an effective amount of a triterpenyl ester of organic acid other than triterpenyl esters of dibasic saturated fatty acids. A pharmaceutical composition for treating hyperlipidemia which comprises a pharmaceutical carrier and an effective amount of cyclobranol as an active ingredient.

  一种除阿魏酸三萜酯和单盐基及二盐基饱和脂肪酸三萜酯以外的有机酸三萜酯。一种除阿魏酸酯、单基和二基饱和脂肪酸酯以外的有机酸三萜酯的生产工艺，包括三萜醇与相应有机酸的酸卤化物反应。一种治疗高脂血症的药物组合物，包括药物载体和有效量的有机酸三萜酯（二元饱和脂肪酸三萜酯除外）。一种治疗高脂血症的药物组合物，它包括一种药物载体和有效量的作为活性成 分的环烷醇。
• Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
  申请人：NOVARTIS AG

  公开号：US10058534B2

  公开（公告）日：2018-08-28

  The present invention relates to compounds of formula I: in which n, m, X, Y1, R1, R2, R3, R4 and R5 are defined in the Summary of the Invention; capable of being both potent antagonists and degraders of estrogen receptors. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with aberrant estrogen receptor activity.

  本发明涉及式 I 的化合物： 其中 n、m、X、Y1、R1、R2、R3、R4 和 R5 在本发明的摘要中定义；能够成为雌激素受体的强效拮抗剂和降解剂。本发明进一步提供了制备本发明化合物的工艺、包含此类化合物的药物制剂以及使用此类化合物和组合物治疗与雌激素受体活性异常有关的疾病或紊乱的方法。